Skip to navigation | Skip to main content | Skip to footer
Menu Search the University of Manchester siteSearch
Search type

Alternatively, use our A–Z index

Dr Stephen Fowler (MD) - publications

List of publications

2014

  • Stephen J Fowler, 2, Gaël Tavernier, Robert Niven. (2014). High blood eosinophils predict sputum eosinophilia in severe asthma. J Allergy Clin Immunol, eScholarID:235317
  • Rattray, N.J.W., Hamrang, Z., Trivedi, D.K., Goodacre, R., Fowler, S.J. (2014). Taking your breath away: metabolomics breathes life in to personalized medicine. Trends in Biotechnology, eScholarID:235315 | DOI:10.1016/j.tibtech.2014.08.003
  • Hart, A., Sugumar, K., Milan, S., Fowler, S. & Crossingham, I (2014). Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev, 5, CD002996. eScholarID:235313 | PMID:24817558 | DOI:10.1002/14651858.CD002996.pub3

2013

  • Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanović, and the U-BIOPRED Study Group. (2013). Application of ‘omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J, eScholarID:196236 | DOI:10.1183/09031936.00078812
  • Ibrahim B, Marsden P, Morris J, Smith J, Nilsson M, Fowler SJ. (In-press). Metabolomic Analysis of Exhaled Breath Condensate by NMR Spectroscopy Discriminates Inflammatory Phenotypes in Asthma. Allergy, eScholarID:196235

2012

  • Basanta M, Ibrahim B, Dockry R, Douce D, Morris M, Singh D, Woodcock A, Fowler SJ. (2012). Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respiratory Research, 13(August), art72. eScholarID:179258 | DOI:10.1186/1465-9921-13-72
  • Basanta M, Ibrahim B, Douce D, Morris M, Woodcock A, Fowler SJ. (2012). Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. Journal of Breath Research, 6(2), 026002. eScholarID:179259 | DOI:10.1088/1752-7155/6/2/026002

2011

  • Ibrahim B, Basanta M, Cadden P, Singh D, Douce D, Woodcock A, Fowler SJ. (2011). Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax, 66(9), 804. eScholarID:127622 | DOI:10.1136/thx.2010.156695

2010

  • Basanta, M., Jarvis, R., Xu, Y., Blackburn, G., Tal-Singer, R., Woodcock, A., Singh, D., Goodacre, R., Thomas, C. & Fowler, S (2010). Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst, 135(2), 315. eScholarID:79581 | PMID:20098764 | DOI:10.1039/b916374c

2009

  • Fowler SJ, Langley SJ, Truman NJ, Simpson A, Woodcock AA, Custovic A. (2009). The long term effects of allergen sensitization and exposure in adult asthma: a prospective study. World Allergy Organization Journal, 2, 83-90. eScholarID:8202 | DOI:10.1097/WOX.0b013e3181a45f96

2008

  • John Firth, Paul Roberts, Stephen Fowler. (Ed.) (2008). Medical Masterclass. Royal College of Physicians of London. eScholarID:8116
  • (2008). Multiple Chapters. In John Firth, Paul Roberts, Stephen Fowler (Ed.), Medical Masterclass. (pp. -). Royal College of Physicians of London. eScholarID:8135
  • (2008). Respiratory System. In John Firth (Ed.), Medical Masterclass. (pp. -). Royal College of Physicians of London. eScholarID:8150

2007

  • Basanta M, Singh D, Fowler S, Wilson I, Dennis R, Thomas CL. (2007). Increasing analytical space in gas chromatography-differential mobility spectrometry with dispersion field amplitude programming. Journal of chromatography A, 1173, 129-138. eScholarID:8159

2006

  • Fowler SJ, French J, Screaton N, Foweraker J, Condliffe A, Haworth C, Exley A, Bilton D. (2006). Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J, 28( 6), 1204-10. eScholarID:1d30600

2003

  • Currie G, Lee D, Dempsey O, Fowler SJ, Cowan L, Lipworth B. (2003). A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics. Br J Clin Pharmacol, 55( 6), 609-15. eScholarID:1d30137
  • Currie G, Fowler SJ, Lipworth B. (2003). Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis. Ann Allergy Asthma Immunol, 90( 2), 194-8. eScholarID:1d30221
  • Currie G, Haggart K, Lee D, Fowler SJ, Wilson A, Brannan J, Anderson S, Lipworth B. (2003). Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy, 33( 6), 783-8. eScholarID:1d12405 | DOI:10.1046/j.1365-2222.2003.01688.x
  • Orr L, Fowler SJ, Lipworth B. (2003). Relationship between changes in quality of life and measures of lung function and bronchial hyper-responsiveness during high-dose inhaled corticosteroid treatment in uncontrolled asthma. Am J Respir Med, 2( 5), 433-8. eScholarID:1d30018
  • Fowler SJ, Lipworth B. (2003). Relationship of skin-prick reactivity to aeroallergens and hyperresponsiveness to challenges with methacholine and adenosine monophosphate. Allergy, 58( 1), 46-52. eScholarID:1d12406 | DOI:10.1034/j.1398-9995.2003.23779.x

2002

  • Fowler SJ, Hall I, Wilson A, Wheatley A, Lipworth B. (2002). 5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists. Eur J Clin Pharmacol, 58( 3), 187-90. eScholarID:1d30794
  • Currie G, Fowler SJ, Wilson A, Sims E, Orr L, Lipworth B. (2002). Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma. Thorax, 57( 10), 865-8. eScholarID:1d30228
  • Dempsey O, Fowler SJ, Wilson A, Kennedy G, Lipworth B. (2002). Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma. Chest, 122( 1), 151-9. eScholarID:1d30577
  • Fowler SJ, Currie G, Lipworth B. (2002). Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone. J Allergy Clin Immunol, 109( 6), 929-35. eScholarID:1d12408 | DOI:10.1067/mai.2002.123869
  • Fowler SJ, Orr L, Sims E, Wilson A, Currie G, McFarlane L, Lipworth B. (2002). Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate. Chest, 122( 2), 618-23. eScholarID:1d12407

2001

  • Fowler SJ, Wilson A, Griffiths E, Lipworth B. (2001). Comparative in vivo lung delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone, with plastic spacer, or with cardboard tube. Chest, 119( 4), 1018-20. eScholarID:1d29916
  • Fowler SJ, Orr L, Wilson A, Sims E, Lipworth B. (2001). Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. Br J Clin Pharmacol, 52( 1), 93-5. eScholarID:1d31209
  • Wilson A, Fowler SJ, Martin S, White P, Gardiner Q, Lipworth B. (2001). Evaluation of the importance of head and probe stabilisation in acoustic rhinometry. Rhinology, 39( 2), 93-7. eScholarID:1d30795
  • Fowler SJ, Lipworth B. (2001). Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol. Br J Clin Pharmacol, 51( 4), 359-62. eScholarID:1d29915
  • Fowler SJ, Lipworth B. (2001). Salmeterol and inhaled corticosteroids in patients with persistent asthma. JAMA, 286( 24), 3076-7; author reply 3077-8. eScholarID:1d30573

2000

  • Fowler SJ, Dempsey O, Sims E, Lipworth B. (2000). Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype. Am J Respir Crit Care Med, 162( 4 Pt 1), 1318-22. eScholarID:1d30085